Rospotrebnadzor has begun comprehensive studies in Burundi
03  09.2025
At the Joint Russian-Burundi Center for the Study and Prevention of Infections in Bujumbura, research work has begun, which Rospotrebnadzor is conducting with specialists from the National Institute of Public Health of the Republic of Burundi.
The monograph “Bacterial and viral pathogens of community-acquired pneumonia in children” has been published
25  08.2025
The monograph was prepared by the staff of the laboratory of metagenomics and molecular indication of pathogens.

Laboratory of Immunochemistry

Home  »  Structure  »  Laboratories  »  Laboratory of Immunochemistry
Print version

Head of the laboratory – Honored Scientist of the Russian Federation, Doctor of Biological Sciences (DSc. in Biology), Professor

Viktor V. Novikov

The laboratory of biochemistry was organized in 1969.Research was aimed at studying the structure and function of serum proteins in order to develop therapeutic and prophylactic blood products, as well as at studying the immunological properties of various classes of immunoglobulins. 

Directions of activities:

  • Development of immunoglobulin preparations suitable for intravenous administration and study of physicochemical and biological properties, as well as improvement of the quality of existing and developed preparations.

  • Development of diagnostic preparations and test systems for quantitative determination of human serum proteins.

  • Study of the role of infectious agents - pathogens of gastroenterological pathology - in the development of local and systemic shifts in autoimmune homeostasis.

  • Development of a new generation of genetically engineered vaccines for the prevention of viral infections.

    Laboratory achievements:
  • An industrial method has been developed for obtaining the first immunoglobulin preparation in the USSR for intravenous administration. Developers headed by Academician of the Academy of Medical Sciences of the USSR I.N. Blokhinawere awarded the USSR State Prize.
  • An experimental laboratory technology for obtaining the medicinal preparation ceruloplasmin has been developed.
  • Experimental test systems have been developed to determine a wide range of autoantibodies and serum proteins.
  • A new molecular platform has been developed for obtaining antiviral vaccines based on virus-like particles of norovirus and chimeric recombinant proteins.
  • Prototypes of recombinant vaccines have been developed to prevent norovirus, coronavirus infections, and infections caused by the ECHO-30 virus.

Prospects:

  • In 2019 the researches on development of recombinant vaccine of new generation for prevention of an enteroviral infection are initiated.

Phone: +7(831) 469-79-56 Victor V. Novikov

                          469-79-55 general issues

E-mail: lab.imchem@nniiem.ru

Address: 603950, Nizhny Novgorod, Malaya Yamskaya st., 71, 7th floor.

Go to the top